Designed to support patients prescribed IDACIO▼ (adalimumab)
You will need the unique code provided on the access card in your starter pack.
IDACIO is the Fresenius Kabi brand name of a biologic medicine called adalimumab.1 IDACIO is used to help treat some chronic conditions that happen when the body's immune system wrongly attacks itself. This is known as an autoimmune disease.2
There are more than 80 types of autoimmune disorder.3 They occur when the immune cells in our body that usually fight ‘foreign invaders’ like bacteria and viruses and start to attack the body’s own cells by mistake.2 This causes inflammation and damage.2 Autoimmune diseases can affect different areas of the body, for example the joints, the skin or the gut.2
Biologic medicines can be prescribed by a specialist doctor under specific circumstances for certain types of autoimmune condition including:1
Biologic medicines are large, complex molecule medicines that are made using living cells.4 They may be used to treat a range of long-term illnesses, including those caused by autoimmune disease.4
The European Commission states "a biosimilar medicine is developed to be highly similar to an existing biological medicine".4 When a biosimilar is developed, the original biological medicine is known as ‘the reference medicine’.4 Biosimilars can be developed once the reference medicine has been available to patients for a number of years.4 During its development, a biosimilar is studied in a number of different ways, as shown below.5
.
You will need the unique code provided on the access card in your starter pack.
1. Fresenius Kabi receives European Commission approval for adalimumab biosimilar IDACIO®. Available at: https://www.fresenius-kabi.com/gb/news/fresenius-kabi-receives-european-commission-approval-for [Accessed March 2020]
2. Autoimmune diseases: Types, symptoms, causes and more. Available at: https://www.healthline.com/health/autoimmune-disorders [Accessed March 2020]
3. Campbell AW. Autoimmunity and the gut. Autoimmune Dis. 2014; 152428
4. What I need to know about biosimilar medicines. Information guide for patients. European Medicines Agency. Available at: https://ec.europa.eu/docsroom/documents/26643/attachments/1/translations/en/renditions/native%5BAccessed [Accessed March 2020]
5. Biosimilars in the EU. Information guide for healthcare professionals. European Medicines Agency. https://www.ema.europa.eu/en/documents/leaflet/biosimilars-eu-information-guide-healthcare-professionals_en.pdf [Accessed March 2020]
002/KABICARE/FKUK-IRL April 2020
Complete the registration form below to gain access to KabiCare. You will be asked to create a password when you register. You can find the access code on the access card in your starter kit.
Once registered, use the fields below to log in.
You are leaving the KabiCare website now. Please note that Fresenius Kabi have no affiliation or control over the content available on external third-party websites.
Continue